InvestorsHub Logo
Followers 0
Posts 4052
Boards Moderated 0
Alias Born 01/21/2013

Re: None

Wednesday, 08/20/2014 4:27:02 PM

Wednesday, August 20, 2014 4:27:02 PM

Post# of 55244
from 2Q

NOTE 6– INTELLECTUAL PROPERTY RIGHTS
Therapy Cells Inc announced in 2013 that on12 February 2013, US patent
8,372,644 was awarded Dr P Casey, et al. The Assignee
under that patent number is Transplantation Ltd, a company registered in New Zealand. Transplantation Ltd has
exclusively
invested in Therapy Cells Inc a licence for the use of the process for equine and human applications. Due to funding constraints
we have been unable to progress the approval process from the US Food and Drug Administration (FDA) for human applications.
Our funding activity has increased significantly over the last quarter and we are close to finalising a long-term funding
arrangemet that will allow us to fast-track the FDA process